Watchful Waiting

"Watchful Waiting" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Clinical management approach wherein immediate therapy is not provided but there is a period of observation during which periodic tests monitor patient and the progression of the illness. (Driffield T, Smith PC Med Decis Making. 2007 Mar-Apr;27(2):178-88)

Descriptor ID	D057832
MeSH Number(s)	N04.761.559.590.900
Concept/Terms	Watchful Waiting Watchful Waiting Waiting, Watchful Waitings, Watchful Watchful Waitings

Below are MeSH descriptors whose meaning is more general than "Watchful Waiting".

Health Care [N]
Health Services Administration [N04]
Quality of Health Care [N04.761]
Outcome and Process Assessment (Health Care) [N04.761.559]
Outcome Assessment (Health Care) [N04.761.559.590]
Watchful Waiting [N04.761.559.590.900]

Below are MeSH descriptors whose meaning is related to "Watchful Waiting".

Below are MeSH descriptors whose meaning is more specific than "Watchful Waiting".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Watchful Waiting" by people in this website by year, and whether "Watchful Waiting" was a major or minor topic of these publications.

Bar chart showing 102 publications over 15 distinct years, with a maximum of 12 publications in 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2011	2	3	5
2012	1	3	4
2013	4	3	7
2014	5	1	6
2015	6	2	8
2016	4	1	5
2017	4	0	4
2018	7	2	9
2019	6	5	11
2020	7	3	10
2021	8	4	12
2022	2	5	7
2023	3	2	5
2024	3	5	8
2025	1	0	1

Below are the most recent publications written about "Watchful Waiting" by people in Profiles.

Goss LB, Liu M, Zheng Y, Guo B, Conti DV, Haiman CA, Kachuri L, Catalona WJ, Witte JS, Lin DW, Newcomb LF, Darst BF. Polygenic Risk Score and Upgrading in Patients With Prostate Cancer Receiving Active Surveillance. JAMA Oncol. 2025 Feb 01; 11(2):168-171.

View in: PubMed
Bernhardt M, Weinhold L, Bremmer F, Chan E, Cheng L, Collins K, Downes M, Greenland N, Hommerding O, Iczkowski KA, Jufe L, Kreft T, van Leenders G, Oxley J, Perry-Keene J, Reis H, Schmid M, Tsuzuki T, Wobker S, Wiliamson SR, Kweldam C, Kristiansen G. Unexpectedly high variability in determining tumour extent in prostatic biopsies: implications for active surveillance. Histopathology. 2025 Mar; 86(4):627-639.

View in: PubMed
Chappidi MR, Lin DW, Westphalen AC. Role of MRI in Active Surveillance of Prostate Cancer. Semin Ultrasound CT MR. 2025 Feb; 46(1):31-44.

View in: PubMed
Lasmanovich R, Shvero A, Kleinmann N. Upper tract urothelial carcinoma: conservative management - intraluminal adjuvant therapy, and surveillance. Curr Opin Urol. 2025 01 01; 35(1):68-74.

View in: PubMed
Al Tannir AH, Tentis M, Maring M, Patin B, Biesboer EA, Golestani S, Pokrzywa CJ, Peschman J, Murphy PB, Morris RS, Carver TW, de Moya MA. Can Concurrent Traumatic Hemopneumothorax be Safely Observed? J Surg Res. 2024 12; 304:400-407.

View in: PubMed
Apolo AB, Ballman KV, Sonpavde G, Berg S, Kim WY, Parikh R, Teo MY, Sweis RF, Geynisman DM, Grivas P, Chatta G, Reichert ZR, Kim JW, Bilen MA, McGregor B, Singh P, Tripathi A, Cole S, Simon N, Niglio S, Ley L, Cordes L, Srinivas S, Huang J, Odegaard M, Watt C, Petrylak D, Hoffman-Censits J, Wen Y, Hahn O, Mitchell C, Tan A, Streicher H, Sharon E, Moon H, Woods M, Halabi S, Perez Burbano G, Morris MJ, Rosenberg JE. Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma. N Engl J Med. 2025 Jan 02; 392(1):45-55.

View in: PubMed
Newcomb LF, Schenk JM, Zheng Y, Liu M, Zhu K, Brooks JD, Carroll PR, Dash A, de la Calle CM, Ellis WJ, Filson CP, Gleave ME, Liss MA, Martin F, McKenney JK, Morgan TM, Tretiakova MS, Wagner AA, Nelson PS, Lin DW. Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer. JAMA. 2024 06 25; 331(24):2084-2093.

View in: PubMed
Ross AE, Iwata KK, Elsouda D, Hairston J, Russell D, Davicioni E, Proudfoot JA, Shore ND, Schaeffer EM. Transcriptome-Based Prognostic and Predictive Biomarker Analysis of ENACT: A Randomized Controlled Trial of Enzalutamide in Men Undergoing Active Surveillance. JCO Precis Oncol. 2024 04; 8:e2300603.

View in: PubMed
Wright JL, Schenk JM, Gulati R, Beatty SJ, VanDoren M, Lin DW, Porter MP, Morrissey C, Dash A, Gore JL, Etzioni R, Plymate SR, Neuhouser ML. The Prostate Cancer Active Lifestyle Study (PALS): A randomized controlled trial of diet and exercise in overweight and obese men on active surveillance. Cancer. 2024 Jun 15; 130(12):2108-2119.

View in: PubMed
Brown EG, Engwall-Gill AJ, Aldrink JH, Ehrlich PF, Fawcett A, Coakley BA, Rothstein DH, Rich BS, Glick RD, Baertschiger RM, Roach JP, Lautz TB. Unwrapping Nephrogenic Rests and Nephroblastomatosis for Pediatric Surgeons: A Systematic Review Utilizing the PICO Model by the APSA Cancer Committee. J Pediatr Surg. 2023 Nov; 58(11):2128-2134.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement